hidradenitis suppurAtiva (INSMED)
Participation Information
The study has 20 office visits over the course of approximately 61 weeks. $1,600.00 in stipend provided if all regular study visits are attended and completed. You may also be reimbursed for travel expenses that you incur for each completed study visit.
To Qualify, you MUST meet the following INCLUSION CRITERIA:
1.) Age 18 to 80.
2.) Have at least 6 months previous active H.S.
3.) Have H.S. lesions numbering at least 6 total.
To Qualify, you must NOT meet the following EXCLUSION CRITERIA:
1.) Have an active HBV or HCV infection.
2.) Other active skin infections (e.g., bacterial, fungal, or viral) that would interfere with the H.S. evaluation.
3.) History of malignancy (cancer) within the last 5 years.
ClinicalTrials.gov ID NCT06685835
https://clinicaltrials.gov/study/NCT06685835?cond=Hidradenitis%20Suppurativa&intr=Brensocatib&rank=1
